Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Maggiorani, Damien ^a   Manzella, Nicola ^a   Edmondson, Dale E ^b   Mattevi, Andrea ^c   Parini, Angelo ^a   Binda, Claudia ^c   Mialet Perez, Jeanne ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; CARDIOLOGY; DEGRADATION; DISEASES; HEALTH CARE;

CARDIO-VASCULAR DISEASE; HEALTH CARE COSTS; MITOCHONDRIAL ENZYMES; OXIDATIVE DEAMINATION; REACTIVE OXYGEN SPECIES; SCIENTIFIC EVIDENCE; SENESCENCE PROCESS; SUBSTRATE DEGRADATION;

HEART;

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATECHOLAMINE; HYDROGEN PEROXIDE; MITOCHONDRIAL ENZYME; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SEROTONIN;

AGING; CARDIOVASCULAR DISEASE; DEAMINATION; HEART FAILURE; HUMAN; MITOCHONDRIAL DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SENESCENCE; ANIMAL; HEART; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

DISEASES; HEALTH;

AGING; ANIMALS; HEART; HUMANS; MITOCHONDRIAL DYNAMICS; MONOAMINE OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 85019584137     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/3017947     Document Type: Review

References (56)

1. N. Ahmed, R. Mandel, M. J. Fain, "Frailty: An emerginggeriatric syndrome, " The American Journal of Medicine, vol. 120, no. 9, pp. 748-753, 2007.
2. J. Moslehi, R. A. DePinho, E. Sahin, "Telomeres andmitochondria in the aging heart, " Circulation Research, vol. 110, no. 9, pp. 1226-1237, 2012.
3. D. Cesselli, A. P. Beltrami, F. D'Aurizio, et al., "Effects ofage and heart failure on human cardiac stem cell function, "The American Journal of Pathology, vol. 179, no. 1, pp. 349-366, 2011.
4. A. Sheydina, D. R. Riordon, K. R. Boheler, "Molecularmechanisms of cardiomyocyte aging, " Clinical Science (London, England), vol. 121, no. 8, pp. 315-329, 2011.
5. C. Chimenti, J. Kajstura, D. Torella, et al., "Senescence anddeath of primitive cells and myocytes lead to prematurecardiac aging and heart failure, " Circulation Research, vol. 93, no. 7, pp. 604-613, 2003.
6. J. Kajstura, B. Pertoldi, A. Leri, et al., "Telomere shorteningis an in vivo marker of myocyte replication and aging, "The American Journal of Pathology, vol. 156, no. 3, pp. 813-819, 2000.
7. D. J. Baker, B. G. Childs, M. Durik, et al., "Naturally occurringp16(Ink4a)-positive cells shorten healthy lifespan, " Nature, vol. 530, no. 7589, pp. 184-189, 2016.
8. E. Sahin, S. Colla, M. Liesa, et al., "Telomere dysfunctioninduces metabolic and mitochondrial compromise, " Nature, vol. 470, no. 7334, pp. 359-365, 2011.
9. A. Trifunovic, A. Wredenberg, M. Falkenberg, et al., "Prematureageing in mice expressing defective mitochondrial DNApolymerase, " Nature, vol. 429, no. 6990, pp. 417-423, 2004.
10. P. J. Linton, M. Gurney, D. Sengstock, R. M. Mentzer Jr., and R. A. Gottlieb, "This old heart: Cardiac aging andautophagy, " Journal of Molecular and Cellular Cardiology, vol. 83, pp. 44-54, 2014.
11. M. Taneike, O. Yamaguchi, A. Nakai, et al., "Inhibition ofautophagy in the heart induces age-related cardiomyopathy, "Autophagy, vol. 6, no. 5, pp. 600-606, 2010.
12. H. Kanamori, G. Takemura, K. Goto, et al., "Resveratrolreverses remodeling in hearts with large, old myocardialinfarctions through enhanced autophagy-activating AMPkinase pathway, " The American Journal of Pathology, vol. 182, no. 3, pp. 701-713, 2013.
13. A. Hoshino, Y. Mita, Y. Okawa, et al., "Cytosolic p53 inhibitsParkin-mediated mitophagy and promotes mitochondrialdysfunction in the mouse heart, " Nature Communications, vol. 4, p. 2308, 2013.
14. M. Serrano and M. A. Blasco, "Putting the stress on senescence, "Current Opinion in Cell Biology, vol. 13, no. 6, pp. 748-753, 2001.
15. P. Davalli, T. Mitic, A. Caporali, A. Lauriola, D. D'Arca, "ROS, cell senescence, novel molecular mechanisms inaging and age-related diseases, " Oxidative Medicine and CellularLongevity, vol. 2016, Article ID 3565127, p. 18, 2016.
16. S. F. Steinberg, "Oxidative stress and sarcomeric proteins, "Circulation Research, vol. 112, no. 2, pp. 393-405, 2013.
17. Q. Li, D. Su, B. O'Rourke, S. M. Pogwizd, L. Zhou, "Mitochondria-derived ROS bursts disturb calcium cyclingand induce abnormal automaticity in guinea pig cardiomyocyte:a theoretical study, " American Journal of Physiology. Heart and Circulatory Physiology, vol. 308, no. 6, pp. H623-H636, 2014.
18. S. Kurokawa, S. Niwano, H. Niwano, et al., "Cardiomyocytederivedmitochondrial superoxide causes myocardial electricalremodeling by downregulating potassium channelsand related molecules, " Circulation Journal, vol. 78, no. 8, pp. 1950-1959, 2014.
19. A. Terman, T. Kurz, M. Navratil, E. A. Arriaga, U. T. Brunk, "Mitochondrial turnover and aging of long-livedpostmitotic cells: The mitochondrial-lysosomal axis theoryof aging, " Antioxidants & Redox Signaling, vol. 12, no. 4, pp. 503-535, 2010.
20. P. H. Sugden and A. Clerk, "Oxidative stress and growthregulatingintracellular signaling pathways in cardiac myocytes, "Antioxidants & Redox Signaling, vol. 8, no. 11-12, pp. 2111-2124, 2006.
21. A. Nabeebaccus, M. Zhang, A. M. Shah, "NADPH oxidasesand cardiac remodelling, " Heart Failure Reviews, vol. 16, no. 1, pp. 5-12, 2011.
22. P. J. Lijnen, J. F. van Pelt, R. H. Fagard, "Stimulation ofreactive oxygen species and collagen synthesis by angiotensinII in cardiac fibroblasts, " Cardiovascular Therapeutics, vol. 30, no. 1, pp. e1-e8, 2012.
23. X. Y. Wu, A. Y. Luo, Y. R. Zhou, J. H. Ren, "N-acetylcysteinereduces oxidative stress, nuclear factorkappaB activityand cardiomyocyte apoptosis in heart failure, " MolecularMedicine Reports, vol. 10, no. 2, pp. 615-624, 2014.
24. M. Schwarzer, M. Osterholt, A. Lunkenbein, A. Schrepper, P. Amorim, T. Doenst, "Mitochondrial reactive oxygenspecies production and respiratory complex activity in ratswith pressure overload-induced heart failure, " The Journalof Physiology, vol. 592, no. 17, pp. 3767-3782, 2014.
25. S. Rautiainen, E. B. Levitan, M. A. Mittleman, A. Wolk, "Total antioxidant capacity of diet and risk of heart failure:a population-based prospective cohort of women, " TheAmerican Journal of Medicine, vol. 126, no. 6, pp. 494-500, 2013.
26. Z. Tatarkova, S. Kuka, P. Racay, et al., "Effects of aging onactivities of mitochondrial electron transport chain complexesand oxidative damage in rat heart, " Physiological Research, vol. 60, no. 2, pp. 281-289, 2011.
27. D. V. Ziegler, C. D. Wiley, M. C. Velarde, "Mitochondrialeffectors of cellular senescence: Beyond the free radical theoryof aging, " Aging Cell, vol. 14, no. 1, pp. 1-7, 2015.
28. D. F. Dai, L. F. Santana, M. Vermulst, et al., "Overexpressionof catalase targeted to mitochondria attenuatesmurine cardiac aging, " Circulation, vol. 119, no. 21, pp. 2789-2797, 2009.
29. D. E. Edmondson, C. Binda, J. Wang, A. K. Upadhyay, A. Mattevi, "Molecular and mechanistic properties of themembrane-bound mitochondrial monoamine oxidases, " Biochemistry, vol. 48, no. 20, pp. 4220-4230, 2009.
30. N. Kaludercic, J. Mialet-Perez, N. Paolocci, A. Parini, F. Di Lisa, "Monoamine oxidases as sources of oxidantsin the heart, " Journal of Molecular and Cellular Cardiology, vol. 73, pp. 34-42, 2014.
31. S. D. Sivasubramaniam, C. C. Finch, M. J. Rodriguez, N. Mahy, and E. E. Billett, "A comparative study of the expression ofmonoamine oxidase-A and-B mRNA and protein in non-CNS human tissues, " Cell and Tissue Research, vol. 313, no. 3, pp. 291-300, 2003.
32. M. B. Youdim, D. Edmondson, K. F. Tipton, "The therapeuticpotential of monoamine oxidase inhibitors, " NatureReviews. Neuroscience, vol. 7, no. 4, pp. 295-309, 2006.
33. C. Rouzaud-Laborde, N. Hanoun, I. Baysal, et al., "Role of endothelialAADC in cardiac synthesis of serotonin and nitratesaccumulation, " PloS One, vol. 7, no. 7, article e34893, 2012.
34. J. S. Floras, "Sympathetic nervous system activation inhuman heart failure: Clinical implications of an updatedmodel, " Journal of the American College of Cardiology, vol. 54, no. 5, pp. 375-385, 2009.
35. M. D. Esler, A. G. Turner, D. M. Kaye, et al., "Agingeffects on human sympathetic neuronal function, " TheAmerican Journal of Physiology, vol. 268, no. 1, pp. R278-R285, 1995.
36. C. Rouzaud-Laborde, C. Delmas, N. Pizzinat, et al., "Plateletactivation and arterial peripheral serotonin turnover in cardiacremodeling associated to aortic stenosis, " American Journal ofHematology, vol. 90, no. 1, pp. 15-19, 2015.
37. R. R. Nigmatullina, V. V. Kirillova, R. K. Jourjikiya, et al., "Disrupted serotonergic and sympathoadrenal systems inpatients with chronic heart failure may serve as new therapeutictargets and novel biomarkers to assess severity, progressionand response to treatment, " Cardiology, vol. 113, no. 4, pp. 277-286, 2009.
38. A. M. Selim, N. Sarswat, I. Kelesidis, M. Iqbal, R. Chandra, and R. Zolty, "Plasma serotonin in heart failure: Possiblemarker and potential treatment target, " Heart, Lung & Circulation, vol. 26, no. 5, pp. 442-449, 2016.
39. M. W. Rich, "Heart failure in the 21st century: A cardiogeriatricsyndrome, " The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences, vol. 56, no. 2, pp. M88-M96, 2001.
40. J. Mialet-Perez, R. D'Angelo, C. Villeneuve, et al., "Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulatedby caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes, "Journal of Molecular and Cellular Cardiology, vol. 52, no. 2, pp. 502-510, 2012.
41. Y. C. Fu, C. S. Chi, S. C. Yin, B. Hwang, Y. T. Chiu, S. L. Hsu, "Norepinephrine induces apoptosis in neonatalrat cardiomyocytes through a reactive oxygen species-TNFalpha-caspase signaling pathway, " Cardiovascular Research, vol. 62, no. 3, pp. 558-567, 2004.
42. C. Villeneuve, C. Guilbeau-Frugier, P. Sicard, et al., "p53-PGC-1alpha pathway mediates oxidative mitochondrial damage andcardiomyocyte necrosis induced by monoamine oxidase-Aupregulation: Role in chronic left ventricular dysfunctionin mice, " Antioxidants & Redox Signaling, vol. 18, no. 1, pp. 5-18, 2013.
43. G. W. De Keulenaer and D. L. Brutsaert, "Systolic and diastolicheart failure are overlapping phenotypes within the heartfailure spectrum, " Circulation, vol. 123, no. 18, pp. 1996-2004, 2011, discussion 2005.
44. F. S. Loffredo, A. P. Nikolova, J. R. Pancoast, R. T. Lee, "Heart failure with preserved ejection fraction: Molecularpathways of the aging myocardium, " Circulation Research, vol. 115, no. 1, pp. 97-107, 2014.
45. A. Maurel, C. Hernandez, O. Kunduzova, et al., "Agedependentincrease in hydrogen peroxide production bycardiac monoamine oxidase A in rats, " American Journalof Physiology. Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1460-H1467, 2003.
46. R. Pino, P. Failli, L. Mazzetti, F. Buffoni, "Monoamineoxidase and semicarbazide-sensitive amine oxidase activitiesin isolated cardiomyocytes of spontaneously hypertensiverats, " Biochemical and Molecular Medicine, vol. 62, no. 2, pp. 188-196, 1997.
47. O. M. Duicu, R. Lighezan, A. Sturza, et al., "Assessment ofmitochondrial dysfunction and monoamine oxidase contributionto oxidative stress in human diabetic hearts, " OxidativeMedicine and Cellular Longevity, vol. 2016, ArticleID 8470394, p. 12, 2016.
48. N. Kaludercic, E. Takimoto, T. Nagayama, et al., "Monoamineoxidase A-mediated enhanced catabolism of norepinephrinecontributes to adverse remodeling and pump failure in heartswith pressure overload, " Circulation Research, vol. 106, no. 1, pp. 193-202, 2010.
49. P. Umbarkar, S. Singh, S. Arkat, S. L. Bodhankar, S. Lohidasan, and S. L. Sitasawad, "Monoamine oxidase-A is an importantsource of oxidative stress and promotes cardiac dysfunction, apoptosis, fibrosis in diabetic cardiomyopathy, " FreeRadical Biology & Medicine, vol. 87, pp. 263-273, 2015.
50. J. K. Mallajosyula, D. Kaur, S. J. Chinta, et al., "MAO-Belevation in mouse brain astrocytes results in Parkinson'spathology, " PloS One, vol. 3, no. 2, article e1616, 2008.
51. E. J. Anderson, J. T. Efird, S. W. Davies, et al., "Monoamineoxidase is a major determinant of redox balance in humanatrial myocardium and is associated with postoperative atrialfibrillation, " Journal of the American Heart Association, vol. 3, no. 1, article e000713, 2014.
52. E. Marzetti, A. Csiszar, D. Dutta, G. Balagopal, R. Calvani, and C. Leeuwenburgh, "Role of mitochondrial dysfunctionand altered autophagy in cardiovascular aging and disease:from mechanisms to therapeutics, " American Journal ofPhysiology. Heart and Circulatory Physiology, vol. 305, no. 4, pp. H459-H476, 2013.
53. A. M. Orogo and A. B. Gustafsson, "Therapeutic targetingof autophagy: Potential and concerns in treating cardiovasculardisease, " Circulation Research, vol. 116, no. 3, pp. 489-503, 2015.
54. Y. Santin, P. Sicard, F. Vigneron, et al., "Oxidative stress bymonoamine oxidase-A impairs transcription factor EB activationand autophagosome clearance, leading to cardiomyocytenecrosis and heart failure, " Antioxidants & Redox Signaling, vol. 25, no. 1, pp. 10-27, 2016.
55. N. Kaludercic, A. Carpi, T. Nagayama, et al., "Monoamineoxidase B prompts mitochondrial and cardiac dysfunction inpressure overloaded hearts, " Antioxidants & Redox Signaling, vol. 20, no. 2, pp. 267-280, 2014.
56. B. Wu, L. Yu, Y. Wang, et al., "Aldehyde dehydrogenase 2activation in aged heart improves the autophagy by reducingthe carbonyl modification on SIRT1, " Oncotarget, vol. 7, no. 3, pp. 2175-2188, 2016.